Bibliografisk note

Funding Information:
PR has received consultancy and/or speaking fees to Steno Diabetes Centre Copenhagen from Novo Nordisk, Vifor, Sanofi Aventis, Boehringer Ingelheim, Eli Lilly, Gilead, Astellas, AstraZeneca, Bayer, MSD and Mundipharma. PR has received research grants from AstraZeneca and Novo Nordisk and has had shares in Novo Nordisk. AK has received consultancy fees from Novo Nordisk. RSR has shares in Novo Nordisk. BJvS is now an employee at Novo Nordisk. The other authors declare that there is no duality of interest associated with this manuscript.

Funding Information:
information University of Copenhagen; Novo Nordisk We thank all participants and we acknowledge the work of study nurse L. Jelstrup and laboratory technicians D. Riis, T. R. Juhl and J. A. Hermann (Steno Diabetes Centre Copenhagen, Herlev, Denmark). The study was funded by Novo Nordisk A/S and Skibsreder Per Henriksen, R. og hustrus fund. The study also received internal funding from Steno Diabetes Centre Copenhagen and Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet & Cluster for Molecular Imaging, University of Copenhagen, Denmark.

Funding Information:
We thank all participants and we acknowledge the work of study nurse L. Jelstrup and laboratory technicians D. Riis, T. R. Juhl and J. A. Hermann (Steno Diabetes Centre Copenhagen, Herlev, Denmark). The study was funded by Novo Nordisk A/S and Skibsreder Per Henriksen, R. og hustrus fund. The study also received internal funding from Steno Diabetes Centre Copenhagen and Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet & Cluster for Molecular Imaging, University of Copenhagen, Denmark.